BVS、MT和SPRC均为上市前涨幅股

2024-05-07 20:37

Gainers: Clearmind Medicine (CMND) +50% Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment.
FibroGen (FGEN) +22% Q1 earnings call release
Bioventus (BVS) +20% Q1 earnings call release
Zeta Global Holdings (ZETA) +19% Q1 earnings call release
Oscar Health (OSCR) +17% Q1 earnings call release
Golden Sun Health Technology (GSUN) +17% regains compliance with Nasdaq.
Esperion Therapeutics (ESPR) +15% Q1 earnings call release
Mueller Water (MWA) +15% names Marietta Edmunds Zakas as CEO
Symbotic (SYM) +14% Q2 earnings call release
Hims & Hers Health (HIMS) +13% Q1 earnings call release
Mmtec (MTC) +12%.
Thoughtworks (TWKS) +11% names new CEO as Guo Xiao steps down.
SciSparc (SPRC) +10%.
Jumia Technologies (JMIA) +10% Q1 earnings call release
UBS Group (UBS) +9% stock jumps after Q1 returns to profit; maps out cost, capital plans.

More on premarket gainers & stock